Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Cardialen Closes $17M Series B Financing For Heart Rhythm Therapy
Venture Capital

Cardialen Closes $17M Series B Financing For Heart Rhythm Therapy

by vcaonline.com posted 2months ago 44 views
Cardialen is developing a low-energy implantable defibrillation therapy designed to more gently restore normal heart rhythm MINNEAPOLIS, October 10, 2018-- Cardialen, Inc., a medical device company developing a low-energy implantable defibrillation therapy designed to more gently restore normal heart rhythm, announced today the closing of a $17 million Series B investment led by RiverVest Venture Partners, along with Qiming Venture Partners, HBM Healthcare Investments and Cultivation Capital. The financing will be used to advance Cardialen’s clinical program with further human testing of its unpinning termination (UPT) therapy and begin development of an implantable device.

In this article